Oncotarget

Research Papers:

Phospho-kinase profile of colorectal tumors guides in the selection of multi-kinase inhibitors

Gemma Serrano-Heras, María Dolores Cuenca-López, Juan Carlos Montero, Verónica Corrales-Sanchez, Jorge Carlos Morales, Luz-Elena Núñez, Francisco Moris, Atanasio Pandiella and Alberto Ocaña _

PDF  |  HTML  |  Supplementary Files  |  How to cite  |  Order a Reprint

Oncotarget. 2015; 6:31272-31283. https://doi.org/10.18632/oncotarget.5211

Metrics: HTML 1064 views  |   ?  


Abstract

Gemma Serrano-Heras1,*, María Dolores Cuenca-López1,*, Juan Carlos Montero2, Verónica Corrales-Sanchez1, Jorge Carlos Morales1, Luz-Elena Núñez3, Francisco Morís3, Atanasio Pandiella2, Alberto Ocaña1

1Translational Research Unit, Albacete University Hospital, Albacete, Spain

2Cancer Research Center, CSIC-University of Salamanca, Salamanca, Spain

3EntreChem S.L., Oviedo, Spain

*These authors have contributed equally to this work

Correspondence to:

Alberto Ocaña, e-mail: albertoo@sescam.jccm.es, albertocana@yahoo.es

Keywords: colon cancer, EC-70124, kinase inhibitors

Received: July 03, 2015     Accepted: September 10, 2015     Published: September 22, 2015

ABSTRACT

Protein kinases play a central role in the oncogenesis of colorectal tumors and are attractive druggable targets. Detection of activated kinases within a tumor could open avenues for drug selection and optimization of new kinase inhibitors. By using a phosphokinase arrays with human colorectal tumors we identified activated kinases, including the Epidermal Growth Factor Receptor (EGFR), components of the PI3K/mTOR pathway (AKT and S6), and STAT, among others. A pharmacological screening with kinase inhibitors against these proteins helped us to identify a new kinase inhibitor, termed EC-70124 that showed the highest anti-proliferative activity in cell lines. EC-70124 also inhibited cell migration and biochemical experiments demonstrated its effect targeting the PI3K/mTOR pathway. This drug also arrested cells at G2/M and induced apoptosis. Experiments in combination with standard chemotherapy used in the clinical setting indicated a synergistic effect. EC-70124 also reduced tumor growth in vivo and inhibited pS6 in the implanted tumors. In conclusion, by studying the kinase profile of colorectal tumors, we identified relevant activated pathways, and a new multi-kinase compound with significant antitumor properties.


Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.
PII: 5211